26-11-2018 13:58:34

PUMA SE Underperform

Samenvatting: PUMA SE Underperform
Bedrijf:
PUMA SE
Analist:
RBC Capital Markets
Koersdoel:
375 €
Huidige Rating:
Underperform
Koers*:
454,5 €
Afstand tot Koersdoel*:
-17,4917491749175%
Rating update:
Sell
Laatste koers:
69,65 €
Afstand Koersdoel:
438,40631730079%
Analist naam::
Piral Dadhania
K/W-verhouding*:
-
* Zum Zeitpunkt der Analyse
Meer nieuws

Analisten over PUMA SE

16-9-2019 PUMA Overweight Morgan Stanley
13-9-2019 PUMA Hold Baader Bank
11-9-2019 PUMA Hold HSBC
4-9-2019 PUMA Underperform RBC Capital Markets
9-8-2019 PUMA Underperform RBC Capital Markets
meer analisten

Invoer toevoegen

Aandelen in dit artikel

PUMA SE 69,65 1,46% PUMA SE

Laatste Analisten adviezen

20-9-2019 Novo Nordisk Overweight JP Morgan Chase & Co.
20-9-2019 WACKER CHEMIE Neutral JP Morgan Chase & Co.
20-9-2019 Zurich Insurance Buy Goldman Sachs Group Inc.
20-9-2019 Assicurazioni Generali Neutral Goldman Sachs Group Inc.
20-9-2019 AXA Goldman Sachs Group Inc.
20-9-2019 Allianz Neutral Goldman Sachs Group Inc.
20-9-2019 Vodafone Group Buy HSBC
20-9-2019 Commerzbank RBC Capital Markets
20-9-2019 Intesa Sanpaolo Buy HSBC
20-9-2019 UniCredit Buy HSBC
20-9-2019 Deutsche Telekom Buy HSBC
20-9-2019 Airbus Buy Kepler Cheuvreux
20-9-2019 Eni Buy Kepler Cheuvreux
20-9-2019 ProSiebenSat1 Media Neutral Oddo BHF
20-9-2019 RTL Buy Oddo BHF
20-9-2019 Wirecard Buy Kepler Cheuvreux
20-9-2019 BAUER Hold Kepler Cheuvreux
20-9-2019 GlaxoSmithKline Neutral JP Morgan Chase & Co.
20-9-2019 AstraZeneca Overweight JP Morgan Chase & Co.
20-9-2019 Diageo Hold Independent Research GmbH
20-9-2019 Société Générale (Societe Generale Hold Independent Research GmbH
20-9-2019 Novo Nordisk Hold Independent Research GmbH
20-9-2019 Givaudan Buy Merrill Lynch & Co., Inc.
20-9-2019 Air Liquide Buy Merrill Lynch & Co., Inc.
20-9-2019 Akzo Nobel Underperform Merrill Lynch & Co., Inc.
20-9-2019 LANXESS Buy Merrill Lynch & Co., Inc.
20-9-2019 Symrise Buy Merrill Lynch & Co., Inc.
20-9-2019 FUCHS PETROLUB Underperform Merrill Lynch & Co., Inc.
20-9-2019 Evonik Underperform Merrill Lynch & Co., Inc.
20-9-2019 BASF Underperform Merrill Lynch & Co., Inc.
20-9-2019 Shell (Royal Dutch Shell) (A Outperform Credit Suisse Group
20-9-2019 TOTAL Outperform Credit Suisse Group
20-9-2019 Knorr-Bremse Underperform Credit Suisse Group
20-9-2019 Rolls-Royce Goldman Sachs Group Inc.
20-9-2019 RWE Goldman Sachs Group Inc.
20-9-2019 BNP Paribas Buy UBS AG
20-9-2019 Société Générale (Societe Generale Buy UBS AG
20-9-2019 RWE Buy UBS AG
20-9-2019 EON Neutral UBS AG
20-9-2019 Knorr-Bremse Buy UBS AG
20-9-2019 TRATON Buy UBS AG
20-9-2019 Peugeot Neutral UBS AG
20-9-2019 CompuGroup Medical Hold Warburg Research
20-9-2019 BAUER Hold Warburg Research
20-9-2019 AB InBev SA-NV (Anheuser-Busch InBev Outperform Bernstein Research
20-9-2019 AB InBev SA-NV (Anheuser-Busch InBev Neutral UBS AG
20-9-2019 Eni Outperform Bernstein Research
20-9-2019 Novo Nordisk Underperform Jefferies & Company Inc.
20-9-2019 Unilever Underweight Barclays Capital
20-9-2019 Unilever Underweight Barclays Capital